Tag Archives: Adaptive Biotechnologies

October, 2018

September, 2018

May, 2018

November, 2017

July, 2017

June, 2017

January, 2016

  • 8 January

    Pfizer Enters Immuno-Oncology Collaboration with Adaptive Biotechnologies

    NEW YORK & SEATTLE–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and Adaptive Biotechnologies Corporation have entered into a translational research collaboration to leverage next generation sequencing of the adaptive immune system to advance Pfizer’s growing immuno-oncology franchise. Under the terms of the agreement, Pfizer and Adaptive will seek to combine drug development …

April, 2015